Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 55.40
-0.10 (-0.18%)
Sep 18, 2025, 2:36 PM CST
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 9.90 billion as of September 18, 2025. Its market cap has decreased by -15.93% in one year.
Market Cap
9.90B
Enterprise Value
11.40B
Revenue
6.88B
Ranking
n/a
PE Ratio
12.34
Stock Price
55.40
Market Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 9.90B, an increase of 331.55%. That is a compound annual growth rate of 5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 9.90B | -10.50% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | 6.74B | 11.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 322.61B |
| PharmaEssentia | 183.07B |
| Bora Pharmaceuticals Co., LTD. | 87.62B |
| Lotus Pharmaceutical | 49.18B |
| Lumosa Therapeutics | 48.10B |
| Oneness Biotech | 34.10B |
| Polaris Group | 29.47B |
| Center Laboratories | 27.25B |